Welcome to Burg Simpson Eldredge Hersh and Jardine's site, please upgrade your Flash Plugin and enable JavaScript.
Hot Topics
$5.35 million award in insurance company bad faith case
– Read the case summary
"Job-bias cases surge in Colorado, feds say"
– The Denver Post
"FedEx Sued For Not Letting Workers Clock In On Time"
"U.S. Supreme Court upholds right to recover compensation from drug companies for injuries"
– "Wyeth v. Levine Opinion"
– "Court allows drug label lawsuit"
– Wyeth Press Release
"Gadolinium law suits picks up pace"
– Missouri Lawyers Weekly
Wal-Mart Class Action Wage Lawsuits
"Attorney Michael Burg Leads the Hunt for Culprits in Economic Meltdown"
Janet Abaray Spearheads Class Action Suit Against Bengals
Explosion Accidents:
"Pooch alive after
Breck blast"
– Denver Post
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"
– FDA
Yamaha Rhino ATV Rollover Accidents
and Injuries
"UBS Hit by
Another Lawsuit"
– Ben Levinsohn, BusinessWeek
"Hedge Funds
Frozen Shut"
– Matthew Goldstein, BusinessWeek
"MRI Contrast Can Cause Disease – Gadolinium Blamed
For Problems"
– Dayle Cedars
7News, Denver, CO
Results
$5,350,000
Jury awards a Burg Simpson client $5.35 million for Bad Faith Breach of Insurance Contract.
$1,300,000
Jury award to Englewood company to total more than $1 million for breach of fiduciary duties in Shareholder Class Action Case.
$690,000,000
Global settlement with Eli Lilly and Company regarding its product Zyprexa negotiated by a plaintiffs' attorney group including members of Burg Simpson.
$5,800,000
Hines, et al, vs. Cody Gas Company, et al: verdict for injuries, damages, losses from gas explosion.
CLICK HERE FOR MORE INFORMATION
Our Offices
40 Inverness Drive East
Denver, CO 80112
Phone: 303.792.5595
Fax: 303.708.0527
WYOMING OFFICE
Phone: 307.527.7891
Fax: 307.527.7897
OHIO OFFICE
Phone: 513.852.5600
Fax: 513.852.5611
ARIZONA OFFICE
Phone: 602.508.6040
Litigation Updates
Fosamax Causes Osteonecrosis of the Jaw
This e-mail alert is to inform you about an injury that has been reported by users of Merck's Fosamax. Users of bisphosonates, such as Fosamax, have been experiencing the decay or death of their jawbone. Fosamax is prescribed to treat osteoporosis. Last year alone, doctors wrote an estimated 22.4 million prescriptions for Fosamax. Unlike many injuries, osteonecrosis of the jaw is not common in the general population and thus believed to be a "signature" injury that will aid in the prosecution of these cases.
Lawsuits have begun to be filed and the Wall Street Journal ran an article on April 12, 2006 concerning Fosamax and Osteonecrosis.
If you are interested in a co-counsel relationship with Burg Simpson on Fosamax cases you acquire, please contact Seth A. Katz or Kerry N. Jardine.
